News
-
GoodRx Holdings Inc decreased 5.1% to $4.45 after the company reported quarterly results that were ahead of market's expectations but the online pharmacy estimated weaker-than-expected second quarter and full-year results.
Revenue declined to $183.9 million from $203.3 million and the company swung to a net loss of $3.3 million from a profit of $12.3 million and diluted earnings per share was ($0.01) compared to 3 cents a year ago.
Net loss in the quarter was impacted by $25.5 million of stock-based compensation expense, $6.9 million of which related More
May 10, 2023 -
GoodRx Holdings said revenue in the fourth quarter declined to $184 million from $213 million and net loss shrank to $1.9 million from $39.9 million and diluted earnings per share was breakeven compared to a loss of 10 cents from a year ago.
In 2022, revenue increased to $766.5 million from $745.4 million and net loss rose to $32.8 million from $25.2 million and diluted loss per share rose to 8 cents from 6 cents in the previous year.
Mar 1, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 4.45
$ -0.11 -2.31 %
Jan 3, 2025
- 52-Week High/Low
- $9.06 - $4.44
- YTD
- -4.8%
- Trading Volume
- 97,094
- Market Cap Full
- $ 1.8B
- Shares Outstanding
-
412.4M
Mar 31, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | -5% | -5.1% | -40.9% | 34.1% | 6.1% | -4.8% |
| Q2 | - | - | - | - | 4% | -7.7% | -69.4% | -11.7% | 8.2% | - |
| Q3 | - | - | - | - | 8% | 13.9% | -21.1% | 2% | -9.4% | - |
| Q4 | - | - | - | - | -26.1% | -20.3% | -0.2% | 20.1% | -7% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -4.8% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -10.5% | 29.8% | -8.7% | -5.8% | 17.6% | -2.2% | 17.7% | -9.4% | - | - | - | -3.4% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 0% | -21% | -86% | 44% | -30% | -5% |
Earnings
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Q1 | - | - | 0.08 | - | 0.03 | -0.01 |
| Q2 | - | - | - | 0.07 | - | 0.14 |
| Q3 | - | - | - | -0.04 | -0.1 | -0.09 |
| Q4 | - | - | - | -0.09 | -0.01 | - |
| A | 0.1 | 0.2 | -1.1 | -0.1 | -0.1 | 0.04 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | - | 229.9 | 406.2 | 414.7 | 412.4 |
| Jun | - | - | 230.2 | 408.4 | 412.1 | - |
| Sep | - | 227.1 | 241.1 | 411.2 | 413 | - |
| Dec | 111.8 | 226.6 | 274.7 | 410 | 412.9 | - |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Asset Management | |||||
| Inventory / Stock Turnover | - | - | - | - | - |
| Fixed Asset Turnover | 6.6 | 10.2 | 12.2 | 48.5 | 62.5 |
| Total Asset Turnover | 0.5 | 0.5 | 0.4 | 1 | 0.8 |
| Leverage | |||||
| Debt Ratio | 0.7 | 0.6 | 0.6 | 7.6 | 9.8 |
| Debt – Equity Ratio | 0.8 | 0.8 | 0.9 | -1.9 | -1.7 |
| Interest Coverage | 0.1 | 0.3 | -15.3 | 1.9 | 2.3 |
| Equity multiplier | 0.1 | 0.1 | 0.1 | - | - |